A Dark Vector Cognition product

Item 5. Other Information.

2K characters. Original on sec.gov ·

Item 5. Other Information.

(c) Insider Trading Arrangements

During the first quarter 2025, certain executive officers entered into Rule 10b5-1 trading arrangements that are intended to satisfy the affirmative defense of Rule 10b5-1(c). The executive officers’ plans provide for: (i) the sale of all of the shares issued upon vesting for certain outstanding equity awards previously granted to the applicable executive officer, excluding any shares withheld by the company to satisfy tax withholding obligations (see our 2025 Proxy Statement for a description of the company’s equity compensation plans) and, (ii) for three executives, the sale and/or gift of a certain amount of additional shares (see “Additional or Specified Shares” below) held by the applicable executive, that are not sold in connection with the vesting of an outstanding equity award (as described in (i) above), some of which may have been the result of a prior vesting event for the executive.

Below are the details of each applicable Rule 10b5-1 trading arrangement:

NameTitleDate EnteredDate Expires****1Additional or Specified Shares
Steven A. BrozChief Information OfficerJanuary 30, 2025December 31, 20253,801
Susan Patricia GriffithPresident and Chief Executive OfficerMarch 30, 2025February 27, 202615,000
Remi KentChief Marketing OfficerMarch 24, 2025February 6, 20260
John MurphyClaims PresidentMarch 20, 2025February 2, 20268,000
Lori NiederstCustomer Relationship Management PresidentMarch 28, 2025March 31, 20260
Andrew J. QuiggChief Strategy OfficerJanuary 30, 2025January 30, 20260

1 Subject to the plan’s earlier expiration or completion in accordance with its terms.

Additional Information

President and CEO Susan Patricia Griffith’s quarterly letter to shareholders is included as Exhibit 99 to this Quarterly Report on Form 10-Q and in our online shareholders’ report located on our investor relations website at: investors.progressive.com/financials.

Previous: Item 1A. Risk Factors. · Next: Item 6. Exhibits.